[Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
Nieminen
Urpo
U
HUS, sisätaudit, gastroenterologian klinikka. urpo.nieminen@hus.fi
Höök-Nikanne
Johanna
J
Kärkkäinen
Päivi
P
Niemelä
Seppo
S
D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy; D001707:Biopsy, Needle; D001774:Blood Chemical Analysis; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000188:drug therapy; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology*; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
D008727:Methotrexate